Search results
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 2 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with ...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 2 days agoRong Xu, professor of biomedical informatics and director of CWRU’s centre for artificial intelligence in drug discovery said it was an observational...
Colorectal cancer: Immunotherapy drug may help patients avoid surgery
Medical News Today· 3 hours agoPast research shows that treating MMR deficient/MSI-High colorectal cancer tumors can sometimes be...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoOverall survival, complete response or better, very good partial response or better, the rate of...
Researchers identify a key metabolic gene as target for improved cancer immunotherapy
Medical Xpress· 5 hours agoInhibiting this gene through pharmacologic or genetic intervention led to better T-cell infiltration, increasing effectiveness of immunotherapy in a type of pancreatic cancer called PDAC. The ...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 5 days agoAt a median follow-up of 21.8 months, the 12-month estimated PFS rates were 71% with BPd versus 51%...
Opinion | Why Miami’s Approach to Addiction Is Working
New York Times· 9 hours agoMs. Szalavitz is a contributing Opinion writer who covers addiction and public policy. The force...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 6 days agoSquibb (BMS) has received approval from the US Food and Drug Administration for Breyanzi...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoSunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations PR Newswire SHANGHAI, June 2, 2024 The global pivotal WU-KONG1B study investigating sunvozertinib achieved
Drug already available on NHS could help cure deadly form of bowel cancer
Daily Telegraph· 4 days agoPembrolizumab works by blocking the action of a molecule called PD-1 that hides the cancer from the...